Pharma Stocks Jump as Trump’s Tariff Exclusion Sparks Investor Optimism

As of today, March 3, 2025, Nifty Pharma is up over 4% in the opening session, showing a strong rally in the sector ahead of the exclusion of Trump's Reciprocal Tariff. This positive momentum is led by several pharma stocks.

is leading the charge, surging 15%, while is up over 6%. is also performing well, climbing more than 8%. The market's reaction signals investor optimism, anticipating that the exclusion of the tariff will benefit Indian pharma companies by easing export challenges, especially to the U.S. This surge reflects the sector's resilience and the positive outlook for the pharma industry in the coming months. Disclaimer: This post is for informational purposes only and does not constitute investment advice.